(D-Thr2)-Leu-Enkephalin-Thr is an enkephalin analog that includes a D-threonine substitution at position 2, enhancing its binding affinity to opioid receptors. This modification makes the peptide more resistant to enzymatic degradation, making it suitable for studies on pain modulation and neuropeptide signaling. It is commonly used in research exploring the role of opioid peptides in analgesia and neuromodulation.
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More